2,981
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Factors contributing to pre-treatment loss to follow-up in adults with pulmonary tuberculosis: a qualitative evidence synthesis of patient and healthcare worker perspectives

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2148355 | Received 24 Jun 2022, Accepted 12 Nov 2022, Published online: 22 Dec 2022

References

  • Pai M, Behr M, Dowdy D, Dheda K, Divangahi M, Boehme C, et al. Tuberculosis. Nat Rev Dis Prim. 2016;2. DOI:10.1038/nrdp.2016.76.
  • World Health Organization. The end TB strategy. J Chem Inf Model. 2013;53:1689–13. doi: 10.1021/ci400128m.
  • World Health Organization. Global tuberculosis report. Geneva: World Health Organization; 2021.
  • Ministry of Health. National strategic plan report. Kenya; Vol. 600. 2019; 19–29.
  • Subbaraman R, Jhaveri T, Nathavitharana R. Closing gaps in the tuberculosis care cascade: an action-oriented research agenda. J Clin Tuberc Other Mycobact Dis. 2020;19:100144.
  • MacPherson P, Houben R, Glynn J, Corbett E, Kranzer K. Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis. Bull World Health Organ. 2014;92:126–138.
  • Tripathy J, Srinath S, Naidoo P, Ananthakrishnan R, Bhaskar R. Is physical access an impediment to tuberculosis diagnosis and treatment? A study from a rural district in North India. Public Health Action. 2013;3:235–239.
  • Thomas B, Subbaraman R, Sellappan S, Suresh C, Lavanya J, Lincy S, et al. Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening. BMC Infect Dis. 2018;18:1–11. DOI:10.1186/s12879-018-3039-3
  • Mulaku M, Ochodo E, Steingart K, Young T. Perspectives and experiences of patients and health care workers on pre-treatment loss to follow up in adults with pulmonary tuberculosis: protocol for qualitative evidence synthesis. OSF Preprints; 2021.
  • Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: eNTREQ. BMC Med Res Methodol. 2012;12:1–8.
  • Zawedde-Muyanja S, Musaazi J, Manabe Y, Katamba A, Nankabirwa J, Castelnuovo B, et al. Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda. PLoS One. 2020;15:1–12. DOI:10.1371/journal.pone.0241611
  • Covidence. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation. https://www.covidence.org/
  • The SURE Collaboration. SURE guides for preparing and using evidence-based policy briefs 5. Identifying and addressing barriers to implementing policy options the SURE collaboration. 2011;15.
  • World bank. World bank list of economies. [cited. 2022 Jan 20]. Available from: datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
  • World Health Organization. WHO global lists of high-burden countries for tuberculosis (TB), TB/HIV and TB (MDR/RR-TB),2021-2025. Geneva: WHO; 2021.
  • Rees R, Caird J, Dickson K, Vigurs C, Thomas J. ‘It’s on your conscience all the time’: a systematic review of qualitative studies examining views on obesity among young people aged 12–18 years in the UK. BMJ Open. 2014;4:e004404.
  • Lester S, Lorenc T, Sutcliffe K, Khatwa M, Stansfield C, Sowden A, et al. What helps to support people affected by adverse childhood experiences? A review of evidence. London: EPPI-Centre, Social Science Research Unit, Institute of Education, University of London; 2019.
  • Harris J, Booth A, Cargo M, Hannes K, Harden A, Flemming K, et al. Cochrane qualitative and implementation methods group guidance series - paper 2: methods for question formulation, searching and protocol development for qualitative evidence synthesis. J Clin Epidemiol. 2018;97:39–48.
  • Glenton C, Colvin C, Carlsen B, Swartz A, Lewin S, Noyes J, et al. Barriers and facilitators to the implementation of lay health worker programmes to improve access to maternal and child health: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2013;(10):CD010414. doi:10.1002/14651858.CD010414.pub2
  • Lewin S, Booth A, Glenton C, Munthe-Kaas H, Rashidian A, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings : introduction to the series. Implement Sci. 2018;13:1–10. DOI:10.1186/s13012-017-0688-3
  • Squire S, Belaye A, Kashoti A, Salaniponi F, Mundy C, Theobald S. Lost’ smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? ’Int J Tuberc Lung Dis. 2005;9:25–31.
  • Sharma N, Chandra S, Dhuria M, Kohli C, Chopra K, Aggarwal N, et al. Meso level multi-disciplinary approach for reduction of pre-treatment loss to follow-up in revised national tuberculosis control program, Delhi, India. Indian J Tuberc. 2017;64:281–290. DOI:10.1016/j.ijtb.2017.05.010
  • Stalin P, Manikandan M, Antony V, Murugan N, Singh Z, Kisku1 K, et al. Identifying and addressing factors contributing to pretreatment loss to follow-up of tuberculosis patients referred for treatment from medical colleges in Pondicherry : an implementation research. Indian J Community Med. 2020;45:27–31. DOI:10.4103/ijcm.IJCM_118_19
  • Mwansa-Kambafwile J, Jewett S, Chasela C, Ismail N, Menezes C. Initial loss to follow up of tuberculosis patients in South Africa : perspectives of program managers. BMC Public Health. 2020;20:4–11.
  • Thomas B, Suresh C, Lavanya J, Lindsley M, Galivanche A, Sellappan S, et al. Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India. BMJ Glob Heal. 2020;5:1–13.
  • Pillai D, Purty A, Prabakaran S, Singh Z, Soundappan G, Anandan V. Initial default among tuberculosis patients diagnosed in selected medical colleges of Puducherry: issues and possible interventions. Int J Med Sci Public Heal. 2015;4:957.
  • Mandal A, Basu M, Das P, Mukherjee S, Das S, Roy N. Magnitude and reasons of initial default among new sputum positive cases of pulmonary tuberculosis under RNTCP in a district of West Bengal, India. South East Asia J Public Heal. 2015;4:41–47.
  • Mugauri H, Shewade H, Dlodlo R, Hove S, Sibanda E. Bacteriologically confirmed pulmonary tuberculosis patients: loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012–2016. Int J Infect Dis. 2018;76:6–13.
  • Rawat J, Biswas D, Sindhwani G, Kesharwani V, Masih V, Chauhan BS. Diagnostic defaulters: an overlooked aspect in the Indian revised national tuberculosis control program. J Infect Dev Ctries. 2012;6:20–22.
  • Wagstaff A, van Doorslaer E, Burger R. SMS nudges as a tool to reduce tuberculosis treatment delay and pretreatment loss to follow-up. A randomized controlled trial. PLoS One. 2019;14:1–14.
  • Munro S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4:1230–1245.
  • Sajjad S, Sajid N, Fatimi A, Maqbool N, Baig-Ansari N, Amanullah F. The impact of structured counselling on patient knowledge at a private TB program in Karachi. Pak J Med Sci. 2020;36:S49–54.
  • Aamir S, Latif N, Basit A. Role of counselling to facilitate compliance to the dots for the treatment of tuberculosis. Arch Pulmonol Respir Care. 2016;2:028–31.
  • Duarte R, Lönnroth K, Carvalho C, Lima F, Carvalho A, Muñoz-Torrico M, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2018;24:115–119.
  • Hargreaves J, Boccia D, Evans C, Adato M, Petticrew M, Porter J. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–662.
  • World Health Organization. Guidance for national strategic planning for tuberculosis. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.